Efficacy and Safety of Baricitinib in Sjogren's Syndrome

Clinical trial NCT05016297 · COMPLETED

Trial details

NCT number: NCT05016297
Sponsor: Peking Union Medical College Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sjogren's Syndrome

Start date: 2022-07-14
Primary completion: 2024-08-22
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.